Objective: The surgical site infection (SSI) rate in vascular surgery after groin incision for lower extremity revascularization can lead to significant morbidity and mortality. This trial was designed to study the effect of negative pressure wound therapy (NPWT) on SSI in closed groin wounds after lower extremity revascularization in patients at high risk for SSI.
Surgical site infections (SSIs) of groin incisions after lower extremity revascularization occurs in #30% of patients. [1] [2] [3] [4] [5] This high rate of SSI is surprising given that clean surgical wounds should have SSI rate of <2%. 6, 7 Vascular surgery performed for peripheral arterial disease has one of the highest rates of SSI. 8 SSI leads to a longer duration of hospital stay, and higher rates of readmissions, reoperations, graft failures, and mortality. 1, 2, 5, [8] [9] [10] These infections lead to significantly higher medical costs through higher rates of readmissions and reinterventions. 11 There have been a number of risk factors identified for SSIs after groin incision in lower extremity revascularization such as obesity, diabetes, dialysis, previous femoral cutdown, and presence of critical limb ischemia. 1, 2, [12] [13] [14] [15] However, the surgeon can often only control operative factors and not patient factors to reduce the incidence of SSI. Therefore, use of any adjunctive therapy to lower SSI in patients at high risk of SSI if found effective, may benefit patients significantly by reducing morbidity and mortality. There has been increase in the use of negative pressure wound therapy (NPWT) in primary closed wounds to lower the SSI rate with varied results across multiple surgical specialities. 16, 17 A retrospective study by Matatov et al 18 showed a significantly lower rate of SSI with NPWT in closed groin wounds after revascularization of the lower extremity. No other specific wound dressing has previously been shown to be more effective at lowering SSI. 16 The NPWT may promote wound healing by modulated expression of cytokines and growth
From the Division of Vascular Surgery, Department of Surgery, a and Division of factors, leading to differential extracellular remodelling and wound healing. 19 The objective of this study was to perform a randomized, controlled trial to study the role of NPWT on SSI in primarily closed groin incisions after lower extremity revascularization in vascular surgery patients.
METHODS
The complete trial design and methodology have been previously published. 20 In brief, a single-center, randomized, controlled trial was performed at Victoria Hospital of London Health Science Center in London, Ontario, Canada. Patients with one of the following three risk factors for SSIs were enrolled in the trial: obesity defined as a body mass index of >30 kg/m 2 , previous femoral artery exposure, or presence of minor or major ischemic tissue loss. Patients with preexisting groin infection, a known allergy to dressing material, or those who could not be followed postoperatively were excluded from the study. Once the revascularization procedure was complete, all wounds were closed primarily by preference of the attending surgeon. Then, eligible patients were randomized to NPWT or a standard sterile gauze dressing using an Internet-based software, sealedenvelope.com (London, UK), using block randomization. NPWT or standard gauze dressing was applied sterilely in the operating room. The trial used Prevena Incision Management System (Kinetic Concepts, San Antonio, Tex).
In the postoperative period, NPWT remained on until either hospital discharge or postoperative day 8, whichever occurred earlier. Once the NPWT was removed, the wound was examined for signs of infection. The standard group had the dressing removed on postoperative day 2, and then had daily dressing changes with inspection of the wound. Once discharged, both groups were followed up in the clinic at 30 and 90 postoperative days. Wounds were inspected at each clinic visit by a wound specialist nurse, who was blinded to the treatment groups. If she was uncertain, the staff physician determined the presence or absence of a SSI. An SSI could also be diagnosed by the patient care team if there were clinical signs and symptoms of infection.
The primary outcome was the incidence of SSI within 30 days of revascularization. SSI was diagnosed using the center for disease control guideline as a superficial or deep infection. 21 The Szilagyi classification of vascular wound infection was also used to classify the infection. 22 The secondary outcomes measured were duration of hospital stay, SSI within 90 days, reoperation and readmission rate owing to SSI within 90 days, and mortality within 90 days. The sample size of 48 patients per group (96 patients total) was predetermined with alpha of 0.05 and 80% power using reduction in infection rate with NPWT from 30% in the standard dressing decrease to 6% in the NPWT group based on a previous retrospective study. 18 All statistical analyses were performed using SPSS Statistics version 20.0 (IBM, Armonk, NY). The continuous variables were analyzed using the Student t test and categorical variables were compared using c 2 or Fisher's exact tests depending on the number of events. The level of statistical significance was set at a P < .05. The Western University ethics board approved the trial (REB 104871) and individual patient consent was obtained. This trial is registered under Clinicaltrials.gov (NCT02084017). We obtained a research grant from Western University (London, Ontario, Canada) and Kinetic Concepts provided the Prevena systems; the authors alone, and not the grantees, had full responsibility for the final study design, data collection, statistical analysis, and manuscript writing.
RESULTS
We randomized 102 patients from August 2014 to December 2015. There were 49 patients in the standard group and 53 in the NPWT group (Fig) . The majority of patients were elderly males with risk factors for peripheral arterial disease such as hypertension, diabetes, and smoking (Table I) . Critical limb ischemia was present in 65% of patients in the standard group and 70% in NPWT group. In the standard group, patients were classified as a high risk for SSI owing to having previous groin incisions in 26%, body mass index of >30 kg/m 2 in 35%, and presence of ischemic tissue loss in 39% compared with the NPWT group which had 33%, 42%, and 25%, respectively (Table II) . The most common revascularization procedure performed was femoral to distal bypass, followed by femoral endarterectomy, femoralefemoral crossover, aortoebifemoral bypass, and axillary femoral bypass (Table III) . The majority of patients were classified as American Society of Anesthesiologists class 3 or 4. The mean duration of operation was 2.5 hours in both groups. All incisions in the study were vertical, with the exception ARTICLE HIGHLIGHTS Recommendation:
The study failed to confirm that negative pressure dressings reduces surgical site infections at the groin compared with standard dressing, although using negative pressure dressings resulted in reduced duration of stay. of 14 oblique incisions (8 in the experimental group and 6 in the control group). Most commonly, the great saphenous vein was used as a conduit followed by polytetrafluoroethylene, Dacron, and bovine pericardium (Table III) . In-hospital results showed only one in-hospital SSI in the groin after revascularization in each group (standard group 2% vs NPWT 2%; P ¼ .74; Table IV) . Both patients had a superficial SSI involving the subcutaneous layer only and both were treated with empiric antibiotics. There were, however, significantly shorter mean durations of hospital stay in the NPWT group (6.4 days) compared with the standard group (8.9 days; P ¼ .02). One patient had the NPWT removed early (<24 hours) owing to an inability to achieve adequate seal postoperatively, but did not experience SSI. There were no inhospital deaths in either groups.
There was a lower 30-day SSI rate in the NPWT group compared with the standard group (11.3% vs 18.4%; P ¼ .24; Table IV ). The difference in SSI rate within 90 days postoperative period between the NPWT group and the standard group was also nonsignificant (13.2% % vs 22.4%; P ¼ .26). Furthermore, there was no difference between the standard group and NPWT group in terms of readmission rate (4.1% vs 3.8%; P ¼ .93) or reoperation rate (2.0% vs 3.8%; P ¼ .53) related to SSI. There were three reoperations owing to SSI (one in the standard group vs two in the NPWT group) where irrigation and debridement was carried out in all patients, with one patient requiring a sartorius muscle flap. There was no graft failure within 90 days of operation. There were three deaths during the 90-day follow-up period (two in the standard group vs one in the NPWT group, P ¼ .47) owing to pneumonia, prostate cancer, and lung cancer.
DISCUSSION
There was no difference in the 30-day SSI rate in high risk-groin wounds after lower extremity revascularization in the NPWT group compared with the standard dressing group. There was a lower SSI rate of 11% in the NPWT group compared with 18% in the standard group. A lower than expected infection rate and a lower than expected treatment effect compared with retrospective studies 18 resulted in the trial being underpowered. Previous attempts to lower SSI using platelet-rich plasma or silver alginate dressings have failed to show an improvement in the SSI rate, with both standard and control groups having nearly identical infection rates. 4, 23 Therefore, the role of NPWT in lowering the SSI in groin wounds after revascularization should be studied further (20) 13 (25) Bovine pericardium 3 (7) 11 (20) Other 7 (14) 12 (23) ASA, American Society of Anesthesiologists; NPWT, negative pressure wound therapy; OR, operating room; PTFE, polytetrafluoroethylene. Data are presented as mean 6 standard deviation or number (%). Readmission rate for SSI 2 (4) 2 (4) .93
Reoperation rate for SSI 1 (2) 2 (4) .53
Mortality within 90 days 2 (4) 1 (2) .47
NPWT, Negative pressure wound therapy; SSI, surgical site infection. Data are presented as mean 6 standard deviation or number (%).
to see if an absolute risk reduction of 7.1% (39% relative risk reduction) in this study is significant with a sufficiently large sample size. A recent meta-analysis of NPWT for closed surgical incisions for various procedures has shown a significant reduction in wound infections compared with the standard of care.
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The in-hospital SSI rate was <2% in both groups and did not differ significantly. Recent data from the Vascular Quality Initiative Registry from the Society of Vascular Surgery have shown an in-hospital SSI rate from lower extremity bypass of 4.8%. 14 The majority of SSI occurred once the patient was discharged from the hospital. The 30-day postoperative SSI, excluding SSI diagnosed during hospital admission, was 16.4% in standard group and 9.4% in NPWT group. A previous study showed postdischarge SSI of 14% in high-risk patients for SSI in vascular surgery. 5 Because the majority of SSI occurred after discharge, frequent monitoring of surgical wounds after discharge and early detection of SSI is prudent to prevent progression of superficial to deep infections. The NPWT group had the Prevena device removed at discharge or before postoperative day 8, whichever occurred first. A total of 33 patients (62%) had the NPWT removed at the time of the discharge. It is not clear whether longer application of NPWT may have been beneficial. In future studies, the NPWT device should be left on for maximum of 7 days in all patients, because the majority of SSI occurred after being discharged from the hospital. There was a significantly shorter duration of hospital stay by 2.5 days in the NPWT group compared with the standard group. Longer duration of hospital stay has also been identified as an independent risk factor for readmission after discharge. 9 The mechanisms through which the NPWT results in a shortened duration of stay are unknown, but the NPWT group may have experienced less pain owing to less frequent dressing changes or improved mobility from the NPWT providing enhanced lymphatic flow resulting in reduced swelling of the limb. Further economic analysis may be warranted to study the cost effectiveness of NPWT. SSI can further add to the cost of health care; it is a leading cause for readmissions, reoperations and graft failures.
1,2,9 A previous retrospective study has demonstrated a lower rate of deep SSI in the NPWT group, but our study did not detect a difference. 18 There was no difference in readmissions or reoperations owing to SSI between the two groups. Furthermore, there was no in-hospital mortality and no 90-day postoperative mortality related to SSI in this study. A larger sample size is required to power a study given the lower than expected treatment effect and lower than expected baseline SSI, particularly with respect to the rate of deep SSI, readmissions, reoperations, or mortality related to SSI. This trial is limited by being a single-center study with a relatively small sample size. The infection rate and treatment effect were lower than expected, which lead to the sample size being too small to detect any statistical significance in difference in the SSI rate. The power of our study was 0.17; therefore, our study has a high probability of a type II error. Given our absolute risk reduction of 7% in SSI a future trial with 400 patients in each arm would be appropriately powered to detect a difference if one truly exists. It may be beneficial to leave the NPWT device on for the maximum duration in all patients in the NPWT group because the majority of SSIs occurred after discharge. Although SSI was diagnosed by a wound specialist nurse who was blinded to the study group, patients and surgeons were not blinded to the treatment they had received.
CONCLUSIONS
There was a trend for a lower SSI rate in the NPWT group compared with the standard dressing group, although statistical significance was not achieved owing to a lower than expected SSI rate and lower than expected treatment effect. There was a significantly shorter mean duration of hospital stay in the NPWT group, which may provide significant cost savings. The SSI rate in groin wounds after lower limb revascularization remains high despite being a clean procedure and remains a significant source of readmission and reoperation.
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